ADVFN ADVFN

Hot Features

Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

5,02
0,03
(0,60%)
Fermé 07 Juin 10:00PM
5,00
-0,02
(-0,40%)
Après les heures de négociation: 1:55AM

Maravai LifeSciences Holdings Inc (MRVI) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
5,00
( 0,20% )
Prix Achat
3,80
Prix Vente
6,24
Volume échangé
2 270 188
4,92 Fourchette du Jour 5,13
1,99 Plage de 52 semaines 5,21
Cap du marché
Clôture Veille
4,99
Ouverture
4,99
Dernière Transaction
100
@
5
(formt)
Dernière heure de transaction
Volume financier
US$ 11 286 167
VWAP
4,9715
Volume moyen (3 m)
US$ 2 194 317
Actions en circulation
147 506 164
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-6,44
Bénéfice par action (BPA)
-0,72
Chiffre d'affairess (LTM)
204,73M
Bénéfice net (LTM)
-104,56M

À propos de Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operat... Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
San Diego, United States
Fondé
2026
Maravai LifeSciences Holdings Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker MRVI. Le dernier cours de clôture d'Maravai LifeSciences était de US$4,99. Au cours de la dernière année, les actions de Maravai LifeSciences ont été négociées dans une fourchette de prix de US$ 1,99 à US$ 5,21.

Maravai LifeSciences compte actuellement 147 506 164 actions en circulation. La capitalisation boursière d'Maravai LifeSciences est de US$737,53 million. Maravai LifeSciences a un ratio cours/bénéfice (ratio PE) de -6.44.

MRVI Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.337.066381156324.675.214.6733551134.86059388CS
40.6113.89521640094.395.21432692774.6220496CS
121.7151.97568389063.295.212.823968663.89841779CS
261.2834.40860215053.725.212.817750593.75723947CS
522.81128.3105022832.195.211.9916649733.29431004CS
156-8.34-62.518740629713.3414.881.66521384116.00024553CS
260-37.99-88.369388229842.9963.551.665199537613.79810514CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences Holdings Inc share price?
The current share price of Maravai LifeSciences Holdings Inc is US$ 5,00
How many Maravai LifeSciences Holdings Inc shares are in issue?
Maravai LifeSciences Holdings Inc has 147 506 164 shares in issue
What is the market cap of Maravai LifeSciences Holdings Inc?
The market capitalisation of Maravai LifeSciences Holdings Inc is USD 737,53M
What is the 1 year trading range for Maravai LifeSciences Holdings Inc share price?
Maravai LifeSciences Holdings Inc has traded in the range of US$ 1,99 to US$ 5,21 during the past year
What is the PE ratio of Maravai LifeSciences Holdings Inc?
The price to earnings ratio of Maravai LifeSciences Holdings Inc is -6,44
What is the cash to sales ratio of Maravai LifeSciences Holdings Inc?
The cash to sales ratio of Maravai LifeSciences Holdings Inc is 3,34
What is the registered address of Maravai LifeSciences Holdings Inc?
The registered address for Maravai LifeSciences Holdings Inc is 10770 Wateridge Circle, San Diego, California, 92121
What is the Maravai LifeSciences Holdings Inc website address?
The website address for Maravai LifeSciences Holdings Inc is www.maravai.com
Which industry sector does Maravai LifeSciences Holdings Inc operate in?
Maravai LifeSciences Holdings Inc operates in the Biotechnology & Life Sciences sector

MRVI Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock